Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Food Hypersensitivity
- E-B-FAHF-2, Multi OIT and Xolair for Food Allergy
- Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients
- Long-term Extension Study of Ligelizumab in Food Allergy
- JAK Inhibition in Food Allergy
- Preventing Anaphylaxis With Acalabrutinib
- Pilot Study on Immunotherapy for the Treatment of Persistant Peanut Allergy
- Behandling af Boern Med Foedevareallergi Med Omalizumab (Xolair)
- Protection From Food Induced Anaphylaxis by Reducing the Serum Level of Specific IgE (Protana).
- Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants
- Clinical Study Using Biologics to Improve Multi OIT Outcomes
- Food Allergen OIT for Shrimp and Cashew
- A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
- Multi OIT to Test Immune Markers After Minimum Maintenance Dose
- Inhibition of Anaphylaxis by Ibrutinib
- E-B-FAHF-2, Multi OIT and Xolair (Omalizumab) for Food Allergy
- The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children
- Study Using Xolair in Rush Multi Oral Immunotherapy in Multi Food Allergic Patients
- Multi Immunotherapy to Test Tolerance and Xolair
- iFAAM: The Impact of Proton-pump Inhibitors (Antacids) on Threshold Dose Distributions
- FARE Peanut SLIT and Early Tolerance Induction
- Probiotic Supplementation in Breastfed Newborn Infants
- Can Vitamin D Supplementation in Infants Prevent Food Allergy in the First Year of Life? The VITALITY Trial
- Baked Egg or Egg Oral Immunotherapy for Children With Egg Allergy
- Mechanisms of Desensitization During Peanut Oral Immunotherapy
- Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
- Effects of Montelukast in Asthmatic Children With and Without Food Allergy
- Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
- Omalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center
- Single Center Food Allergy Oral Immunotherapy Study
- Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance
- A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy
- Trichuris Suis Ova in Peanut and Tree Nut Allergy
- Omalizumab in the Treatment of Peanut Allergy
- Determining the Efficacy and Value of Immunotherapy on the Likelihood of Peanut Tolerance: The DEVIL Study
- Therapeutic Effect of Chinese Herbal Medicine on Food Allergy
- A Study of Sublingual Immunotherapy in Peanut-allergic Children
- Treatment of Egg Allergy in Children Through Oral Desensitization (EGG OIT)
- A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial
- Oral Immunotherapy for Childhood Egg Allergy
- Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008
- Potential Allergens in Wine: Double-blind Placebo-controlled Trial